The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical. The entire left atrial appendage closure device market has been sub-categorized into product and end-user. demand for left atrial appendage closure device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Stroke is a serious risk for patients with atrial fibrillation. Patients with atrial fibrillation are at a higher danger of stroke if not appropriately treated. Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world. The growing prevalence of atrial fibrillation will be driving the growth of the market. Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market. However, implantation of an LAA occluder device also entails short-term and long-term risks. Also, device implantation procedures do not totally eliminate the possibility of blood clots which is hampering the growth of the market.
By Product
- Epicardial LAA Closure Device
- Endocardial LAA Closure Device
By End User
- Hospitals
- Ambulatory Surgical Centers
- Heart Clinics
Source: https://www.valuemarketresearch.com/report/left-atrial-appendage-closure-device-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.